A groundbreaking study presented at ADLM 2024 has uncovered alarming rates of cannabis use during pregnancy, highlighting the need for improved screening and patient education.
A study published in JAMA estimates that adopting new cardiovascular disease risk prediction equations could make nearly 16 million fewer US adults eligible for preventive medications, potentially leading to over 100,000 additional occurrences of myocardial infarction or stroke over 10 years.
A groundbreaking study from Finnish researchers uncovers alarming trends in early-onset dementia among working-age adults, with Alzheimer’s disease cases nearly doubling over the past decade.
A groundbreaking titanium artificial heart with a single moving part has been successfully implanted in a patient with end-stage heart failure, potentially revolutionising treatment options for those awaiting transplantation.
A groundbreaking MIT study published in Nature offers new insights into the cellular mechanisms underlying Alzheimer’s disease, revealing potential targets for interventions to maintain cognitive function.
The HumanIC project, funded by the EU’s Horizon Europe programme, seeks to create a new generation of scientists and engineers who will redefine hospital environments through innovative indoor climate design.
Scientists in the UK have developed the first code of practice for research using stem cell-based embryo models, providing ethical guidelines and governance for this rapidly advancing field.
A groundbreaking gene therapy for Duchenne muscular dystrophy (DMD) has demonstrated significant potential in not only arresting muscle decline but also possibly repairing damaged muscle tissue. This novel treatment, developed by researchers at UW Medicine, utilises a series of protein packets delivered via viral vectors to replace the defective DMD gene within affected muscles.
Research from Mass Eye and Ear demonstrates successful use of CRISPR/Cas9 to target and disrupt a genetic mutation causing hearing loss, offering hope for future treatments in humans.
A landmark British study spanning 15 years has demonstrated that egg freezing success rates are comparable to routine IVF, offering reassurance to women considering this fertility preservation option.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
BiVACOR
Tsai Lab/ MIT Picower Institute
Irene Zorzan and Teresa Rayon, Babraham Institute
Chamberlain Lab